ProCE Banner Activity

Clinical Focus in SCLC: Emerging Insights on B7-H3–Targeted ADCs and Their Transformative Potential in Clinical Practice

Slideset

Downloadable slideset on the efficacy and safety of emerging B7-H3–targeting antibody–drug conjugates used in the management of small-cell lung cancer based on evidence from key clinical trials.

Released: May 12, 2025

Expiration: May 11, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.